Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
biOasis Technologies Ord Shs
BIOAF
Primary Symbol:
V.BTI.H
Healthcare
Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in...
particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:BTI.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on May 11, 2023 3:25pm
RE:RE:FDA Approval of PRX-102 (Elfabrio)
Zwerp says BTI didn't move on the FDA approval of PRX-102. Although that's something less than an astute observation, it's also a ridiculous expectation. The approval may trigger other
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on May 11, 2023 3:07pm
Zacks on PLX:
We expect milestones to be due upon approval from partner Chiesi; however, these amounts have not been disclosed. We update our valuation to reflect the approval of Elfabrio, increasing
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(144)
•••
unclepieman
X
View Profile
View Bullboard History
Comment by
unclepieman
on May 11, 2023 3:03pm
RE:RE:delisting...
good one...? :shrug
(40)
•••
zwerp2000
X
View Profile
View Bullboard History
Comment by
zwerp2000
on May 11, 2023 12:03pm
RE:FDA Approval of PRX-102 (Elfabrio)
awesome! and with the approval, bti didn't budge at all. no volume etc. maybe everyone is failing to see the connection, lol
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on May 10, 2023 4:11pm
RE:RE:FDA Approval of PRX-102 (Elfabrio)
My understanding of xB3 drug development is that, as new chemical entities, the research part of R&D would likely require less work but the preclinical and clinical work could be about the same as
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on May 10, 2023 2:24pm
RE:FDA Approval of PRX-102 (Elfabrio)
"It’s possible, maybe likely, that Chiesi/Protalix would not want to advance an unapproved drug as an xB3 payload." Maybe its a simpler regulatory process for xB3 with an approved drug
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on May 10, 2023 12:33pm
FDA Approval of PRX-102 (Elfabrio)
Protalix and Chiesi have announced that their enzyme replacement therapy for Fabry disease, PRX-102, now called Elfabrio, has been approved by the FDA. You can find a cellphone-friendly version of the
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on May 10, 2023 6:58am
Chiesi/Protalix receive FDA approval for Fabry:
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce FDA Approval of ELFABRIO® (pegunigalsidase alfa-iwxj) for the Treatment of Fabry Disease PLX | 55
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on May 09, 2023 7:03pm
PLX after hours on FDA:
3.2900 +0.37 (+12.67%) After hours: 07:02PM EDT
(302)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on May 08, 2023 7:24pm
RE:delisting...
F*** You!!!!!
(144)
•••
unclepieman
X
View Profile
View Bullboard History
Post by
unclepieman
on May 08, 2023 5:33pm
delisting...
LOL how are we not yet delisted? It's May 8th, no way we have ANY $ left!
(40)
•••
zwerp2000
X
View Profile
View Bullboard History
Comment by
zwerp2000
on May 08, 2023 11:59am
RE:RE:RE:RE:Chiesi/Protalix Announce European Approval:
and what do you have, boom? zilch! nothing! zero! could? yeah, sure. i will believe it when i see it
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on May 06, 2023 8:55am
RE:Bioasis Web Page
BTI still promotes on Twitter with commitment: @BioasisUS · 12h
...more
(87)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on May 06, 2023 5:32am
Bioasis Web Page
https://www.bioasis.us/ Does the Bioasis Web Page appear to have been updated lately? G1945V
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on May 05, 2023 4:00pm
RE:RE:Sometimes it's just timing:
Could be an interesting day to talk to Dr. Jeffrey Cummings. Did you know that he's quoted in Scientific American today? He's probably getting a lot of inbound calls on the news.
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada